Skip to content
ZURAZura Bio Ltd

Earnings

When Zura Bio Ltd reports, what it reported each quarter, and how the stock took the results.

21 quarters. Jun 30, 2021 to Sep 30, 2026. mixed units.

Next results · Q4 2026Projected

Mar 18, before the open

Thu, Mar 18, 2027in 120 days

Projected from its last 8 releases. The company has not named the day yet.

Quarter
Q4 2026 · Ends about Dec 31, 2026
10-K window
Mar 16 – Apr 14

Read against Q4 2025

The same quarter a year earlier, the figures the next ones will be compared with. Thaler holds no estimates.

Revenue
—
Net income
-$17.18M
Net income, change from a year earlier: Q3 2026 n/m, Q2 2026 n/m, Q1 2026 n/m, Q4 2025 n/m
EPS
—
EPS, change from a year earlier: Q3 2026 n/m, Q2 2026 n/m, Q1 2026 n/m, Q3 2025 n/m

Quarter by quarter

Q3 2026-$25.83MNo Q3 2025 on file

Latest results

  1. Q3 2026Oct 27, 2026, before the openThe release+19.9%by the close of Oct 27
    Revenue
    —
    —
    Net income
    -$25.83M
    N/M
    EPS
    -$0.20
    N/M
    On October 27, 2026, Zura Bio Limited (the “Company”) issued a press release announcing its third quarter 2026 financial results.
  2. Q2 2026Aug 11, 2026, before the openThe release1.5%by the close of Aug 11
    Revenue
    —
    —
    Net income
    -$26.30M
    N/M
    EPS
    -$0.21
    N/M
  3. Q1 2026May 7, 2026, before the openThe release7.8%by the close of May 7
    Revenue
    —
    —
    Net income
    -$24.22M
    N/M
    EPS
    -$0.22
    N/M
  4. Q4 2025Mar 19, 2026, after the closeThe release10.7%by the close of Mar 20
    Revenue
    —
    —
    Net income
    -$17.18M
    N/M
    EPS
    —
    —

All quarters

PeriodEndedAnnouncedFiledLagFormRevenueΔ yoyEPS dil.MoveSource trail
FY 2026
Q3 2026Sep 30, 2026Oct 27, 2026 · pre-marketOct 27, 202627 d10-Q——-$0.20+19.9%
Q2 2026Jun 30, 2026Aug 11, 2026 · pre-marketAug 11, 202642 d10-Q——-$0.211.5%
Q1 2026Mar 31, 2026May 7, 2026 · pre-marketMay 7, 202637 d10-Q——-$0.227.8%
FY 2025
Q4 2025derivedDec 31, 2025Mar 19, 2026 · after-hoursMar 19, 202678 d10-K———10.7%
Q3 2025Sep 30, 2025Nov 13, 2025 · pre-marketNov 13, 202544 d10-Q——-$0.2110.0%
Q2 2025Jun 30, 2025Aug 14, 2025 · pre-marketAug 14, 202545 d10-Q——-$0.17+7.8%
Q1 2025Mar 31, 2025May 8, 2025 · pre-marketMay 8, 202538 d10-Q——-$0.19+2.9%
FY 2024
Q4 2024derivedDec 31, 2024Mar 25, 2025 · pre-marketMar 25, 202584 d10-K———+10.0%
Q3 2024Sep 30, 2024Nov 7, 2024 · pre-marketNov 7, 202438 d10-Q——-$0.26+4.0%
Q2 2024Jun 30, 2024Aug 13, 2024 · pre-marketAug 13, 202444 d10-Q——-$0.174.1%
Q1 2024Mar 31, 2024May 9, 2024 · pre-marketMay 9, 202439 d10-Q——-$0.02+1.7%
Earlier years, FY 2021 to FY 2023

Move: the stock from the last close before the release to the first close after it. Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Source filings

10-QOct 27, 2026000011
10-QAug 11, 2026000006
10-QMay 7, 2026031696
10-KMar 19, 2026032080
10-QNov 13, 2025110793
10-QAug 14, 2025001783
10-QMay 8, 2025001100
10-KMar 25, 2025000443
10-QNov 7, 2024001779
10-QAug 13, 2024001371

Provenance

ProvenanceData status and checks

Zura Bio Ltd · CIK 1855644 · Engraved from SEC EDGAR